Jen Borrow
Publications by Year
Research Areas
PARP inhibition in cancer therapy, Radio Frequency Integrated Circuit Design, Advancements in Semiconductor Devices and Circuit Design, Cardiac, Anesthesia and Surgical Outcomes, Enhanced Recovery After Surgery
Most-Cited Works
- → A Phase I–II Study of the Oral PARP Inhibitor Rucaparib in Patients with Germline BRCA1/2 -Mutated Ovarian Carcinoma or Other Solid Tumors(2017)236 cited
- → Data from A Phase I–II Study of the Oral PARP Inhibitor Rucaparib in Patients with Germline <i>BRCA1/2</i>-Mutated Ovarian Carcinoma or Other Solid Tumors(2023)
- → Supplementary Appendix from A Phase I–II Study of the Oral PARP Inhibitor Rucaparib in Patients with Germline <i>BRCA1/2</i>-Mutated Ovarian Carcinoma or Other Solid Tumors(2023)